Mr. Calafiore’s will step down Aug. 31 and take over as CEO of an unnamed orthopedic medtech company, according to a news release. His responsibilities will be reallocated across NuVasive management.
“In my five years at NuVasive, I am very proud of our collective work to transform surgery, advance care and, most importantly, change the lives of patients around the world,” Mr. Calafiore said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.